These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 7178213)

  • 41. Antipsychotic drugs inhibit prolactin release from rat anterior pituitary cells in culture by a mechanism not involving the dopamine receptor.
    West B; Dannies PS
    Endocrinology; 1979 Apr; 104(4):877-80. PubMed ID: 436760
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Physiological concentrations of dopamine decrease adenosine 3',5'-monophosphate levels in cultured rat anterior pituitary cells and enriched populations of lactotrophs: evidence for a causal relationship to inhibition of prolactin release.
    Swennen L; Denef C
    Endocrinology; 1982 Aug; 111(2):398-405. PubMed ID: 6284477
    [No Abstract]   [Full Text] [Related]  

  • 43. Disturbed prolactin responses to dopamine-related substances in patients with acromegaly and hyperprolactinemia.
    Sekiya K; Karashima T; Ikuyama S; Muta K; Kato K; Ibayashi H
    Endocrinol Jpn; 1985 Apr; 32(2):207-14. PubMed ID: 4042986
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A D-2 dopaminergic agonist stimulates secretion of anterior pituitary immunoreactive beta-endorphin in rats.
    Farah JM; Mueller GP
    Neuroendocrinology; 1989 Jul; 50(1):26-32. PubMed ID: 2569171
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of a dopaminergic drug on LH, FSH and prolactin levels in PCO syndrome.
    Venturini PL; Alibrandi MP; Costantini S; Gaggero G; Penna L; Valenzano M; Ragni N
    Acta Eur Fertil; 1981 Sep; 12(3):295-7. PubMed ID: 6803505
    [No Abstract]   [Full Text] [Related]  

  • 46. Changes in adenohypophysial dopamine related to prolactin release.
    Chiocchio SR; Chafuen S; Tramezzani JH
    Endocrinology; 1980 Jun; 106(6):1682-5. PubMed ID: 6768540
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Glycine potentiates the NMDA-induced release of dopamine through a strychnine-insensitive site in the rat striatum.
    Krebs MO; Kemel ML; Gauchy C; Desban M; Glowinski J
    Eur J Pharmacol; 1989 Aug; 166(3):567-70. PubMed ID: 2680525
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dopamine can be released by two mechanisms differentially affected by the dopamine transport inhibitor nomifensine.
    Raiteri M; Cerrito F; Cervoni AM; Levi G
    J Pharmacol Exp Ther; 1979 Feb; 208(2):195-202. PubMed ID: 216794
    [No Abstract]   [Full Text] [Related]  

  • 49. Benserazide and nomifensine in the diagnosis of prolactin-secreting pituitary adenomas.
    Pontiroli AE; Loda G; Roggia A; Scagliola P; Falsetti L
    Acta Endocrinol (Copenh); 1982 Oct; 101(2):171-9. PubMed ID: 7136447
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prolactin release from subpopulations of rat lactotrophs in the presence and absence of dopamine.
    Hu L; Lawson DM
    J Endocrinol; 1996 Jan; 148(1):113-20. PubMed ID: 8568458
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of two enkephalin analogues, morphine sulphate, dopamine and naloxone on prolactin secretion from rat anterior pituitary glands in vitro.
    Bentley AM; Wallis M
    J Endocrinol; 1986 Jun; 109(3):313-20. PubMed ID: 3734666
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The dopamine agonist, PHNO ((+)-4-propyl-9-hydroxynaphthoxazine), inhibits cyclic adenosine 3',5'-monophosphate formation and prolactin release from anterior pituitary cells.
    Login IS; Trugman JM
    Neuropharmacology; 1989 Jun; 28(6):647-50. PubMed ID: 2547181
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of nomifensine on the toxicity of 6-hydroxydopamine for mesotelencephalic dopamine neurons.
    Lees GJ; Kydd RR; Horsburgh RJ; Wright JJ
    Brain Res; 1984 Aug; 308(1):155-8. PubMed ID: 6434148
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Rat anterior pituitary dopaminergic receptors are regulated by estradiol and during lactation.
    Heiman ML; Ben-Jonathan N
    Endocrinology; 1982 Oct; 111(4):1057-60. PubMed ID: 7117191
    [No Abstract]   [Full Text] [Related]  

  • 55. Characterization of the effects of the acute and repeated administration of MK-801 on the release of adrenocorticotropin, corticosterone and prolactin in the rat.
    Pechnick RN; George R; Poland RE
    Eur J Pharmacol; 1989 May; 164(2):257-63. PubMed ID: 2547636
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of estrogen administration on the induction of the plasma prolactin afternoon surge and on anterior pituitary prolactin concentration extracted at different pHs.
    Gala RR; Sensui N; Lawson DM
    Experientia; 1983 Feb; 39(2):212-4. PubMed ID: 6682047
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Vasoactive intestinal polypeptide and dopamine in the hypothalamus and pituitary of ageing rats with prolactinomas.
    Prysor-Jones RA; Silverlight JJ; Jenkins JS; Merry BJ
    Acta Endocrinol (Copenh); 1987 Sep; 116(1):150-4. PubMed ID: 3661055
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cell-density dependence of the rate of prolactin secretion from perifused rat anterior pituitary cells.
    Bentley AM; Wallis M
    J Endocrinol; 1983 May; 97(2):221-8. PubMed ID: 6854191
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Toxic effects of cadmium on the regulatory mechanism of dopamine and serotonin on prolactin secretion in adult male rats.
    Lafuente A; González-Carracedo A; Romero A; Cabaleiro T; Esquifino AI
    Toxicol Lett; 2005 Jan; 155(1):87-96. PubMed ID: 15585363
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Validity of radioimmunoassay for blood and pituitary prolactin in the male rat. Effect of bromocriptine and thyrotropin-releasing hormone].
    André M; Grizard G; Boucher D
    C R Seances Soc Biol Fil; 1981; 175(6):792-800. PubMed ID: 6459824
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.